Peter Ueda

32PUBLICATIONS
90CO-AUTHORS
Molecular targetsPredictive and prognostic markersCardiology (incl. cardiovascular diseases)PharmacogenomicsSexualities
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Oct 09, 2026
GLP-1 receptor agonists and serious adverse events: Evidence, uncertainty and clinical implications.

|Jul 13, 2026
Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study.

|Jun 05, 2026
Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model.

|Apr 17, 2026
Use of Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study.

|Mar 11, 2026
Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model.

Tessa H Reitsma, Carl-Emil Lim, Mari N Gynnild

|Feb 09, 2026
Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk score.

Joris Holtrop, Mari N Gynnild, Matthew Richards

Pageof 6

Frequent Collaborators

6 joint publications

Carl-Emil Lim

5 joint publications

Tomas Jernberg

5 joint publications

Björn Pasternak

4 joint publications

Steven H J Hageman